Trials / Completed
CompletedNCT00178932
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | genetic analysis | genetic assay of blood sample drawn with patient's consent |
| PROCEDURE | genetic assay | genetic assay of blood sample drawn with patient's consent |
Timeline
- Start date
- 1998-11-01
- Primary completion
- 2024-05-16
- Completion
- 2024-05-16
- First posted
- 2005-09-15
- Last updated
- 2025-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00178932. Inclusion in this directory is not an endorsement.